For the year ending 2025-12-31, LFST made $1,424,285K in revenue. $8,734K in net income. Net profit margin of 0.61%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenue | 1,424,285 | 1,250,970 | 1,055,665 | 859,542 |
| Center costs, excluding depreciation and amortization shown separately below | 963,186 | 848,571 | 753,569 | 622,525 |
| General and administrative expenses | 382,198 | 363,062 | 410,793 | 377,993 |
| Depreciation and amortization | 54,753 | 70,950 | 80,437 | 69,198 |
| Total operating expenses | 1,400,137 | 1,282,583 | 1,244,799 | 1,069,716 |
| Income (loss) from operations | 24,148 | -31,613 | -189,134 | -210,174 |
| Gain on remeasurement of contingent consideration | 0 | 1,725 | 3,972 | - |
| Transaction costs | 0 | 827 | 89 | - |
| Interest expense, net | 11,662 | 26,535 | 21,220 | 19,928 |
| Other expense | 123 | 363 | 112 | 218 |
| Total other expense | -11,785 | -26,000 | -17,449 | -22,556 |
| Income (loss) before income taxes | 12,363 | -57,613 | -206,583 | -232,730 |
| Income tax (provision) benefit | 2,700 | -170 | -20,321 | -17,166 |
| Net income (loss) | 9,663 | -57,443 | -186,262 | -215,564 |
| Accretion of redeemable class a units | - | - | 0 | - |
| Unrealized losses on cash flow hedge, net of tax | -929 | -1,374 | - | 3,274 |
| Net loss available to common stockholders/members | - | - | -186,262 | - |
| Comprehensive income (loss) | 8,734 | -58,817 | - | -212,290 |
| Basic Average Shares | 386,016,000 | 379,147,000 | 367,457 | 355,278 |
| Diluted Average Shares | 391,136,000 | 379,147,000 | 367,457 | - |
LifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. (LFST)